• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

World J Gastroenterol . Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients

tetano

Editor, Senior Moderator
World J Gastroenterol


. 2022 Feb 7;28(5):570-587.
doi: 10.3748/wjg.v28.i5.570.
Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients


Arunkumar Krishnan[SUP] 1 [/SUP], Laura Prichett[SUP] 2 [/SUP], Xueting Tao[SUP] 2 [/SUP], Saleh A Alqahtani[SUP] 1 [/SUP], James P Hamilton[SUP] 1 [/SUP], Esteban Mezey[SUP] 1 [/SUP], Alexandra T Strauss[SUP] 1 [/SUP], Ahyoung Kim[SUP] 1 [/SUP], James J Potter[SUP] 1 [/SUP], Po-Hung Chen[SUP] 1 [/SUP], Tinsay A Woreta[SUP] 3 [/SUP]



Affiliations

Abstract

Background: Abnormal liver chemistries are common findings in patients with Coronavirus Disease 2019 (COVID-19). However, the association of these abnormalities with the severity of COVID-19 and clinical outcomes is poorly understood.
Aim: We aimed to assess the prevalence of elevated liver chemistries in hospitalized patients with COVID-19 and compare the serum liver chemistries to predict the severity and in-hospital mortality.
Methods: This retrospective, observational study included 3380 patients with COVID-19 who were hospitalized in the Johns Hopkins Health System (Baltimore, MD, United States). Demographic data, clinical characteristics, laboratory findings, treatment measures, and outcome data were collected. Cox regression modeling was used to explore variables associated with abnormal liver chemistries on admission with disease severity and prognosis.
Results: A total of 2698 (70.4%) had abnormal alanine aminotransferase (ALT) at the time of admission. Other more prevalent abnormal liver chemistries were aspartate aminotransferase (AST) (44.4%), alkaline phosphatase (ALP) (16.1%), and total bilirubin (T-Bil) (5.9%). Factors associated with liver injury were older age, Asian ethnicity, other race, being overweight, and obesity. Higher ALT, AST, T-Bil, and ALP levels were more commonly associated with disease severity. Multivariable adjusted Cox regression analysis revealed that abnormal AST and T-Bil were associated with the highest mortality risk than other liver injury indicators during hospitalization. Abnormal AST, T-Bil, and ALP were associated with a need for vasopressor drugs, whereas higher levels of AST, T-Bil, and a decreased albumin levels were associated with mechanical ventilation.
Conclusion: Abnormal liver chemistries are common at the time of hospital admission in COVID-19 patients and can be closely related to the patient's severity and prognosis. Elevated liver chemistries, specifically ALT, AST, ALP, and T-Bil levels, can be used to stratify risk and predict the need for advanced therapies in these patients.

Keywords: Alanine aminotransferase; Aspartate aminotransferase; Liver injury; Liver tests; Severe acute respiratory syndrome coronavirus 2; bilirubin.
 
Back
Top Bottom